Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 21173375)

Published in Arch Otolaryngol Head Neck Surg on December 01, 2010

Authors

Hilliary N White1, Eric J Moore, Eben L Rosenthal, William R Carroll, Kerry D Olsen, Reneé A Desmond, J Scott Magnuson

Author Affiliations

1: Division of Otolaryngology, Department of Surgery, University of Alabama School of Medicine, BDB Ste 563, 1530 Third Ave S, Birmingham, AL 35294-0012, USA.

Articles citing this

Objective assessment in residency-based training for transoral robotic surgery. Laryngoscope (2012) 2.06

Oncologic Outcomes After Transoral Robotic Surgery : A Multi-institutional Study. JAMA Otolaryngol Head Neck Surg (2015) 1.03

The role of transoral robotic surgery in the management of oropharyngeal cancer: a review of the literature. ISRN Oncol (2012) 1.01

Transoral robotic surgery (TORS) for tongue base tumours. Acta Otorhinolaryngol Ital (2013) 1.01

Transoral robotic surgery for head and neck carcinomas. Eur Arch Otorhinolaryngol (2011) 0.94

Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials. J Clin Oncol (2015) 0.86

Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival. PLoS One (2014) 0.85

Robotic surgery in otolaryngology and head and neck surgery: a review. Minim Invasive Surg (2012) 0.82

The role for surgical management of HPV-related oropharyngeal carcinoma. Head Neck Pathol (2012) 0.82

Assessment of margins in transoral laser and robotic surgery. Rambam Maimonides Med J (2014) 0.78

Transoral robotic surgery in the management of head and neck tumours. Ecancermedicalscience (2013) 0.78

Utility of up-front transoral robotic surgery in tailoring adjuvant therapy. Head Neck (2016) 0.77

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies. Contemp Oncol (Pozn) (2015) 0.76

Up-front and Salvage Transoral Robotic Surgery for Head and Neck Cancer: A Belgian Multicenter Retrospective Case Series. Front Oncol (2017) 0.75

Preliminary study of transoral robotic surgery for pharyngeal cancer in Japan. J Robot Surg (2015) 0.75

Transoral Robotic Surgery in the HPV Era. Rambam Maimonides Med J (2014) 0.75

Transoral robotic surgery in management of oropharyngeal cancers: a preliminary experience at a tertiary cancer centre in India. Int J Clin Oncol (2014) 0.75

Articles by these authors

Vascularized tissue to reduce fistula following salvage total laryngectomy: a systematic review. Laryngoscope (2014) 2.21

Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97

Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One (2010) 1.85

Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope (2009) 1.80

Soft palate perforation during orotracheal intubation facilitated by the GlideScope videolaryngoscope. J Clin Anesth (2007) 1.72

Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma. Mol Imaging Biol (2013) 1.67

Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2011) 1.62

Reexamining the treatment of advanced laryngeal cancer. Head Neck (2010) 1.62

Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope (2006) 1.59

Stereomicroscopic fluorescence imaging of head and neck cancer xenografts targeting CD147. Cancer Biol Ther (2008) 1.57

Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys (2008) 1.56

Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg (2010) 1.52

In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence. Laryngoscope (2006) 1.50

Transoral robotic surgery: a multicenter study to assess feasibility, safety, and surgical margins. Laryngoscope (2012) 1.49

Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Mayo Clin Proc (2012) 1.46

Distraction osteogenesis for cleft palate closure in a canine model. Arch Facial Plast Surg (2005) 1.46

Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope (2008) 1.46

Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: a retrospective study. Ear Nose Throat J (2011) 1.45

A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract. Cancer (2005) 1.43

Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck (2008) 1.42

Utility of CT surveillance for primary site recurrence of squamous cell carcinoma of the head and neck. Head Neck (2010) 1.39

Endoscopic versus traditional approaches for excision of juvenile nasopharyngeal angiofibroma. Laryngoscope (2005) 1.36

Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg (2007) 1.33

Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model. Ann Surg Oncol (2012) 1.30

Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg (2009) 1.29

Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol (2012) 1.28

Locoregionally advanced head and neck cancer treated with primary radiotherapy: a comparison of the addition of cetuximab or chemotherapy and the impact of protocol treatment. Int J Radiat Oncol Biol Phys (2008) 1.27

Facial nerve paralysis secondary to occult malignant neoplasms. Otolaryngol Head Neck Surg (2004) 1.23

An intervention to reduce vaginal douching among adolescent and young adult women: a randomized, controlled trial. Sex Transm Dis (2005) 1.21

Transoral resection of tonsillar squamous cell carcinoma. Laryngoscope (2009) 1.20

Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol (2004) 1.19

Pectoralis major myocutaneous flap vs revascularized free tissue transfer: complications, gastrostomy tube dependence, and hospitalization. Arch Otolaryngol Head Neck Surg (2004) 1.19

The role of free tissue transfer in the reconstruction of massive neglected skin cancers of the head and neck. Arch Facial Plast Surg (2003) 1.17

Prophylactic percutaneous endoscopic gastrostomy tube placement in treatment of head and neck cancer: a comprehensive review and call for evidence-based medicine. JPEN J Parenter Enteral Nutr (2011) 1.16

Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer (2006) 1.16

Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther (2007) 1.16

Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope (2007) 1.16

Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res (2009) 1.16

Salvage surgery for recurrent cancers of the oropharynx: comparing TORS with standard open surgical approaches. JAMA Otolaryngol Head Neck Surg (2013) 1.14

Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg (2008) 1.14

Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13

Use of the endoscopic microdebrider in the management of airway obstruction from laryngotracheal carcinoma. Ann Otol Rhinol Laryngol (2003) 1.11

Assessment and incidence of salivary leak following laryngectomy. Laryngoscope (2012) 1.10

Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinoma. Laryngoscope (2011) 1.09

Prevalence of the chronic sinusitis diagnosis in Olmsted County, Minnesota. Arch Otolaryngol Head Neck Surg (2004) 1.08

IND-directed safety and biodistribution study of intravenously injected cetuximab-IRDye800 in cynomolgus macaques. Mol Imaging Biol (2015) 1.08

Update on the management of parapharyngeal tumours. Curr Opin Otolaryngol Head Neck Surg (2011) 1.08

Learning curve for transoral robotic surgery: a 4-year analysis. JAMA Otolaryngol Head Neck Surg (2013) 1.06

Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma. Laryngoscope (2013) 1.04

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma. J Neurooncol (2008) 1.04

The effects of incremental costs of smoking and obesity on health care costs among adults: a 7-year longitudinal study. J Occup Environ Med (2012) 1.02

Long-term quality of life in young adults treated for oral cavity squamous cell cancer. Ann Otol Rhinol Laryngol (2012) 1.00

Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg (2007) 1.00

Physical activity, quality of life, and burnout among physician trainees: the effect of a team-based, incentivized exercise program. Mayo Clin Proc (2013) 0.99

Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck (2011) 0.99

Glomus jugulare tumor: tumor control and complications after stereotactic radiosurgery. Head Neck (2002) 0.99

Perceptions of harm to health from cigarettes, blunts, and marijuana among young adult African American men. J Health Care Poor Underserved (2013) 0.98

Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice. Clin Exp Metastasis (2004) 0.98

Free tissue transfer versus pedicled flap in head and neck reconstruction. Laryngoscope (2002) 0.98

Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice. Otolaryngol Head Neck Surg (2013) 0.97

Retrospective study and review of polymorphous low-grade adenocarcinoma. Laryngoscope (2006) 0.97

Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer. Laryngoscope (2010) 0.97

(18)F-FDG PET/CT imaging detects therapy efficacy of anti-EMMPRIN antibody and gemcitabine in orthotopic pancreatic tumor xenografts. Mol Imaging Biol (2012) 0.96

Disruptions in the organization of meal preparation and consumption among older cancer patients and their family caregivers. Psychooncology (2010) 0.96

Putting the needs of the patient first: Mayo Clinic's core value, institutional culture, and professionalism covenant. Acad Med (2007) 0.95

Incidence and outcomes of stricture formation postlaryngectomy. Otolaryngol Head Neck Surg (2011) 0.95

Transcriptional profiling by sequencing of oropharyngeal cancer. Mayo Clin Proc (2012) 0.94

Human papillomavirus-associated oropharyngeal squamous cell carcinomas: primary tumor burden and survival in surgical patients. Ann Otol Rhinol Laryngol (2009) 0.94

Expandable tracheal stenting for benign disease: worth the complications? Ann Otol Rhinol Laryngol (2006) 0.94

Closure of post-laryngectomy pharyngocutaneous fistulae. Head Neck Oncol (2011) 0.94